Colombia Serialization and Traceability Compliance

Discover OneScan

Global Regulations

This country has no regulations specific to track and trace of pharmaceuticals within their geographic boundaries. However, manufacturers and distributors in that geography still must meet the regulatory requirements of the countries that their products are delivered to.

目前，哥伦比亚尚未制服国家一级的药品追踪和追查要求。但的确，监控管框架构是在 2007 年通过 1.122 号法律建立的，该法律启用了这一进步。在该地区，运营商和分销商必须关注持续的发展，并确认保守遵循其产品交付目的地国家的监控管道要求。

Summary

Colombia has explored the implementation of a national pharmaceutical traceability system to strengthen supply chain transparency and combat counterfeit medicines. The initiative was introduced by the Ministry of Health and Social Protection and the national regulator Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) through the development of the National Medicines Traceability System (Sistema Nacional de Trazabilidad de Medicamentos).

The objective of this system is to enable identification and monitoring of medicines throughout the supply chain, from manufacturing or importation through distribution to dispensing.

However, serialization and full pharmaceutical track and trace reporting are not currently mandatory in Colombia. The traceability program has remained largely in pilot and regulatory development stages, and nationwide serialization enforcement has not yet been implemented.

Pharmaceutical companies operating in Colombia therefore focus on regulatory compliance and supply chain documentation, while monitoring regulatory updates related to the potential future implementation of traceability requirements.

Labelling Requirements 

Colombian pharmaceutical regulations do not currently mandate serialized barcodes or unique serial numbers on medicine packages.

Packaging must include regulatory labeling elements approved by INVIMA, such as:

  • Product identification
  • Batch or lot number
  • Expiry date

While serialization is not required, some pharmaceutical companies voluntarily include GS1 compliant barcodes for internal logistics or for export markets that require serialization.

These barcodes are not currently linked to a national traceability reporting system.

Regulatory Timeline 

2013
The Colombian Ministry of Health introduced early initiatives to develop a National Medicines Traceability System aimed at improving pharmaceutical supply chain transparency.

2016 to 2019
Pilot discussions and regulatory development activities were conducted to evaluate serialization and traceability technologies.

Present Status
Serialization and national track and trace reporting remain under regulatory evaluation and have not been implemented nationwide.

Reporting Requirements 

Since serialization is not mandated, Colombia does not require traceability reporting for serialized pharmaceutical products.

The proposed traceability framework evaluated the possibility of reporting supply chain events such as commissioning, shipment, receipt, and dispensing, but these requirements have not been implemented in national regulations.

Reporting Hub

Colombia does not currently operate a national pharmaceutical serialization or traceability reporting platform.

The proposed National Medicines Traceability System was intended to create a digital infrastructure to support serialization and supply chain event reporting, but the system has not been fully implemented.

As a result, there is currently no centralized government platform requiring pharmaceutical companies to report serialized product movements.

Aggregation Requirements 

Colombia does not require aggregation of pharmaceutical products at case or pallet level.

Pharmaceutical companies may implement aggregation internally for logistics purposes or to support export compliance in other markets, but this is not mandated by Colombian regulations.

Other Information

Operational Considerations for Industry

  • Pharmaceutical companies operating in Colombia should monitor regulatory developments related to serialization and traceability initiatives.
  • Organizations that export medicines to countries with mandatory serialization requirements may choose to implement internal serialization systems aligned with GS1 standards to support international compliance.

Trusted by Industry Leaders

Smooth and Successful

LSPedia didn’t just provide software; they ensured we were fully compliant. Anytime we had questions, the LSPedia team knew DSCSA inside and out and guided us step by step. That level of expertise made a huge difference during audits. Thanks to their expert team our audit was smooth and successful

Hussein Salman
Lead Pharmacist, Pioneer Pharmacy Services

Constant Commitment

LSPedia shows a constant commitment to improvement; whether it's their support or their product...they're always leveling up. The support team provides consistently thorough follow-up and clear, articulate communication. the support we receive represents a meaningful step up in service and is genuinely appreciated.

Zac Sweeny
EPCIS Data Encoder,Capital Wholesale Drug
Read All TestimonialsView Our Customers

Fill in the form for latest updates

Get in Touch

We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.

Contact Us